MIR9-2 and neoplasm: Although the highlighted differential expression of both MIR512 and MIR9-2 represents a novel finding, we next focused our attention on MIR9-2 as a potential novel tumour suppressor in TGCTs given the similarity of the seed sequence of MIR512 with that of the pluripotency-associated MIR371-373 cluster [38].